COVID-19 News & Education

The latest news, research, and COVID-19 testing information from Labcorp

Latest articles from our blog

Woman putting mask on child to protect from COVID-19

COVID-19 Antibody levels: More may be better

Since the beginning of the COVID-19 pandemic, there’s been a lot of talk about testing. Usually, people are referring to diagnostic testing performed with a nasal swab. However, another type of testing—one that requires a blood test and that you may not know about—has been around nearly the whole time.

That testing is for assessing antibody levels against SARS-CoV-2, the virus that causes COVID-19.

Routine testing for body fever on population during COVID-19 crisis

Demystifying “Flurona”: Dual Viral Infection Is More Common Than You May Think

Since the start of the year, you’ve undoubtedly been hearing more and more about “Flurona.” You may be asking yourself, “Is this even possible? Why are we seeing this now? What can I do to protect myself and my loved ones?” 

people map

Why Viral Variants Like Omicron Are Emerging: A Viral Variation 101

When the COVID-19 pandemic started, we had a singular enemy: the SARS-CoV-2 virus. However, now it seems that there are multiple enemies, with the emergence of variants like Delta and Omicron. How did this happen?

Lady in mask talking to professional

COVID-19 Glossary: Terms to Know

See definitions for words commonly used by professionals when discussing COVID-19.

COVID-19 vs. Flu vs. RSV

COVID-19 vs. Flu vs. RSV: How to tell the difference between respiratory infections

Learn the differences between the flu, COVID-19, and RSV and ways to diagnose them.

COVID-19 News

Nov 30 2021

Labcorp Now Offers Observed Collection for COVID-19 PCR Testing in Over 500 Locations Nationwide, with Plans to Expand to More Than 1,000 Locations

BURLINGTON, N.C., Nov. 30, 2021 — Labcorp (NYSE: LH), a global life sciences company, is now offering observed self-collection for COVID-19 PCR testing in more than 500 of its patient service centers (PSCs) nationwide for people without symptoms or known exposure. By mid-December, the company plans to further expand the COVID-19 PCR test collection service to over 1,000 locations. 

Read more »

View our latest news about advancements in health science, COVID-19, and more.

View more COVID-19 News

Labcorp's COVID-19 PCR Testing

1-2 Days

Average Time to Result from Specimen Pickup

67.8M

Molecular Tests Performed

275K

Molecular Test Capacity Per Day*

8.6M

Antibody Tests Performed

300K

Antibody Test Capacity Per Day*

$0

Tests Offered with No Upfront Costs**

Tracking COVID-19 Variants

Labcorp has been regularly tracking variants of the virus throughout the pandemic. The sensitivity of our PCR test is not impacted by these variants. We have been working with the Centers for Disease Control and Prevention (CDC) to provide sequencing of samples of SARS-CoV-2, the virus that causes COVID-19. Our tests remain effective against variants like Omicron and Delta. This is because they are designed to identify segments of the genetic code that are the least likely to mutate. For more information on variants, see our Viral Variation 101 post or read our Guide to Variants.

Total number of samples sequenced

331,000 as of March 31, 2022

Data covers the U.S. including the District of Columbia and Puerto Rico

Labcorp PCR Test performance confirmed

Checkmark

Alpha (B.1.1.7, Q.1-Q.8)

Checkmark

Beta (B.1.351, B.1.351.2, B.1.351.3)

Checkmark

Delta (B.1.617.2)

Checkmark

Epsilon (B.1.427, B.1.429)

Checkmark

Eta (B.1.525)

Checkmark

Gamma (P.1, P.1.1, P.1.2) 

Checkmark

Iota (B.1.526)

Checkmark

Kappa (B.1.617.1)

Checkmark

Lambda (C.37)

Checkmark

Mu (B.1.621)

Checkmark

Omicron (B.1.1.529, BA.2)

Checkmark

Zeta (P.2)

For more information visit US COVID-19 Cases Caused by Variants on the CDC website. 

Scroll back to top of page